Daily Endocrinology Research Analysis
Analyzed 101 papers and selected 3 impactful papers.
Summary
Three high-impact studies advance endocrinology this cycle: (1) a Nature Metabolism study reveals a catecholamine-independent, brain-evoked pathway that can rapidly catabolize adipose tissue via ATGL-dependent lipolysis under hypoglycemia/hypoinsulinemia; (2) mechanistic work in Diabetes shows α-cell glucagon/GLP-1 paracrine signaling destabilizes β-cell microtubules to enhance insulin secretion; (3) a large cohort analysis in Diabetes Care links afternoon–evening moderate-to-vigorous physical activity with lower incident type 2 diabetes risk at constant activity volume.
Research Themes
- Adipose lipolysis pathways beyond catecholamines
- Islet paracrine crosstalk shaping β-cell cytoskeleton and secretion
- Chronobiology of physical activity and diabetes prevention
Selected Articles
1. A catecholamine-independent pathway controlling adaptive adipocyte lipolysis.
Using a brain-evoked fat-depletion mouse model, the authors identify a powerful, catecholamine-independent lipolytic program that rapidly catabolizes even stable adipose depots under concurrent hypoglycemia and hypoinsulinemia. This pathway requires ATGL and involves downregulating cell-autonomous lipolytic brakes such as G0s2, and is recapitulated in tumor-associated cachexia.
Impact: This study reveals a paradigm-shifting, neurosystemic mechanism for whole-body lipid mobilization that operates independently of the sympathetic catecholamine axis. It reframes our understanding of adipose resilience and identifies regulatory nodes (ATGL, G0S2) with therapeutic potential in cachexia and metabolic disease.
Clinical Implications: Targeting catecholamine-independent lipolysis regulators (e.g., ATGL activation or G0S2 modulation) could open new strategies to treat cancer cachexia and refractory adiposity states, but careful translational work is needed to avoid worsening glycemic instability in diabetes.
Key Findings
- Brain-evoked adipose catabolism depleted all fat depots, including constitutive bone marrow adipose tissue, without changes in food intake.
- Lipolysis required adipose triglyceride lipase (ATGL) and was independent of local nerves, sympathetic nervous system, and catecholamines.
- Concurrent hypoglycemia and hypoinsulinemia activated a potent lipolytic state by downregulating lipolysis inhibitors such as G0s2.
- The catecholamine-independent program delipidated classical depots and was reproduced in tumor-associated cachexia mice.
Methodological Strengths
- Integrated genetic, surgical, and chemical perturbations to causally map the pathway
- Demonstration across multiple adipose depots including constitutive bone marrow fat and a cachexia model
Limitations
- Preclinical murine model; no human interventional validation
- Potential off-target systemic effects of inducing hypoglycemia/hypoinsulinemia not addressed clinically
Future Directions: Define the central circuits triggering this neurosystemic program, test pharmacologic modulation of ATGL/G0S2 in cachexia, and validate biomarkers and safety in early human studies.
Several adipose depots, including constitutive bone marrow adipose tissue, resist conventional lipolytic cues. However, under starvation, wasting or cachexia, the body eventually catabolizes stable adipocytes through unknown mechanisms. Here we developed a mouse model of brain-evoked depletion of all fat, including stable constitutive bone marrow adipose tissue, independent of food intake, to study this phenomenon. Genetic, surgical and chemical approaches demonstrated that catabolism of stable adipocytes required adipose triglyceride lipase-dependent lipolysis but was independent of local nerves, the sympathetic nervous system and catecholamines. Instead, concurrent hypoglycaemia and hypoinsulinaemia activated a potent catabolic state by suppressing lipid storage and increasing catecholamine-independent lipolysis via downregulation of cell-autonomous lipolytic inhibitors including G0s2. This was also sufficient to delipidate classical adipose depots and was recapitulated in tumour-associated cachexic mice. Overall, this defines unique adaptations of stable adipocytes to resist lipolysis in healthy states while isolating a potent catecholamine-independent neurosystemic pathway by which the body can rapidly catabolize all adipose tissues.
2. Paracrine Hormonal Signals From Islet α-Cells Regulate Microtubule Dynamics in β-Cells to Promote Insulin Secretion in Mouse and Human Islets.
α-cell hormones acting via GcgR and GLP-1R destabilize β-cell microtubules, accelerating granule availability and enhancing insulin secretion in mouse and human islets. Islets with higher α:β ratios demonstrate more dynamic microtubules and greater glucose-stimulated insulin secretion; this effect is blunted by high-fat diet.
Impact: This work uncovers a cytoskeletal mechanism by which α-cell paracrine signals fine-tune β-cell function, integrating islet architecture with secretory efficiency. It provides a mechanistic bridge linking glucagon/GLP-1 action to β-cell granule dynamics.
Clinical Implications: Therapeutics that modulate glucagon/GLP-1 signaling or β-cell microtubule dynamics could optimize insulin secretion, informing combination incretin strategies and islet engineering approaches.
Key Findings
- Activation of glucagon receptor (GcgR) or GLP-1 receptor (GLP-1R) destabilizes β-cell microtubules and increases insulin secretion.
- Blocking GcgR/GLP-1R attenuates glucose-induced microtubule remodeling and reduces secretion.
- Islets with higher α:β ratios show more dynamic microtubules and greater insulin output; proximity to α-cells accelerates β-cell remodeling.
- High-fat diet dampens the α-cell–driven microtubule dynamics and secretory enhancement.
Methodological Strengths
- Cross-species validation in mouse and human islets with receptor-specific manipulations
- Integration of live-cell imaging of microtubules with functional secretion readouts
Limitations
- Primarily ex vivo islet studies; limited in vivo system-level validation
- Clinical impact inferred; no direct human intervention trial
Future Directions: Map downstream cytoskeletal effectors, quantify spatial paracrine gradients in vivo, and test whether modulating microtubule dynamics augments incretin-based therapies.
UNLABELLED: The microtubule network in β-cells attenuates insulin secretion by pulling insulin secretory granules away from the plasma membrane. Thus, high-glucose-induced microtubule remodeling is required for robust glucose-stimulated insulin secretion. We now demonstrate that hormones secreted by α-cells regulate microtubule dynamics in β-cells through receptors for glucagon (GcgR) and glucagon-like peptide 1 (GLP-1R). Activation of GcgR or GLP-1R destabilizes microtubules in β-cells, accompanied by increased insulin secretion. In contrast, inhibiting these receptors attenuates high-glucose-induced microtubule destabilization and decreases secretion. Supporting the physiological significance of this regulation, β-cells in islets with a higher α-cell-to-β-cell ratio exhibit more dynamic microtubules than those with a lower ratio, and a high-fat diet challenge in mice, which can compromise β-cell secretion, attenuates this effect in their islets. Within individual islets, β-cells located near α-cells show faster microtubule remodeling upon glucose stimulation than those more distant from α-cells. Consequently, islets with a higher α-cell-to-β-cell ratio secrete more insulin in response to glucose stimulation and plasma membrane depolarization, results recapitulated by exogenous glucagon stimulation or chemically induced microtubule destabilization in islets with lower α-cell-to-β-cell ratios. These combined results suggest that α-cells use glucagon-mediated and/or GLP-1-mediated paracrine signaling to fine-tune β-cell secretion via microtubule remodeling. ARTICLE HIGHLIGHTS: Glucagon/glucagon-like peptide 1 sensitizes glucose-induced microtubule remodeling in β-cells. Microtubule density in islets inversely correlates with the α-cell-to-β-cell ratio. Glucose-stimulated insulin secretion levels in single islets positively correlate with their α-cell-to-β-cell ratio. Glucagon and microtubule destabilization mobilize the same granule pool.
3. Associations of Moderate-to-Vigorous Physical Activity Timing With Type 2 Diabetes Incidence in UK Biobank and Prevalent Glycemic Measures in NHANES.
Across UK Biobank and NHANES, accelerometer-based analyses show that, for a given total MVPA volume, afternoon–evening activity is associated with the lowest incident T2D risk and with modestly better glycemic profiles. Timing appears to matter in addition to quantity.
Impact: This is a large, device-measured, bi-cohort analysis linking the timing of physical activity to diabetes risk, providing pragmatic guidance for lifestyle interventions beyond total activity volume.
Clinical Implications: When counseling patients on physical activity, clustering MVPA in the afternoon–evening may confer additional diabetes prevention benefits at equivalent volumes, pending individualized considerations (work shifts, sleep, comorbidities).
Key Findings
- In UK Biobank (n=84,528), after adjusting for total MVPA, afternoon–evening MVPA (15:00–24:00) showed the lowest incident T2D risk versus early morning reference.
- In NHANES (n=6,998), afternoon/early evening MVPA was modestly associated with more favorable glycemic measures and lower diabetes prevalence after total MVPA adjustment.
- Timing effects were independent of total MVPA volume, highlighting chrono-activity as a distinct behavioral target.
Methodological Strengths
- Large sample sizes with accelerometer-derived MVPA timing across two independent populations
- Consistency of associations after adjustment for total MVPA volume
Limitations
- Observational design with potential residual confounding and selection bias
- NHANES analyses are cross-sectional; UK Biobank follow-up duration not specified in the abstract
Future Directions: Randomized trials manipulating exercise timing, mechanistic studies on circadian–metabolic alignment, and implementation work in diverse, shift-working populations.
OBJECTIVE: We assessed the association between timing of moderate-to-vigorous physical activity (MVPA) with incident type 2 diabetes (T2D) and glycemic measures. RESEARCH DESIGN AND METHODS: Regression models were used to assess associations between accelerometer-derived MVPA timing and incident T2D in UK Biobank (UKB) (n = 84,528, prospective), prevalent diabetes, and glycemic measures in the National Health and Nutrition Examination Survey (NHANES) (n = 6,998, cross-sectional). RESULTS: In UKB, with early morning (0500-0959) MVPA as reference and before adjustment for total MVPA, "variable-timing" MVPA was associated with the lowest incident T2D risk; while after adjustment, afternoon-evening MVPA (1500-2400) showed the lowest incident T2D risk. In NHANES, afternoon/early evening MVPA was weakly associated with more favorable glycemic measures and lower diabetes prevalence after adjustment for total MVPA. CONCLUSIONS: When keeping total MVPA volume constant, clustering MVPA in the afternoon-evening was associated with the strongest reduction in incident T2D risk, fewer prevalent diabetes, and more favorable glycemic measures.